Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
Recruiting · NCT06584318 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Intermittent hypoxia intervention
What this trial is about
This study aims to explore the safety and efficacy of intermittent hypoxia intervention on patients with colorectal cancer.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with colorectal cancer between ages of 18 and 65 years.
- Colorectal cancer stage Ⅰ,Ⅱ.
- Subjects or their legally authorized representative can provide informed consent.
Exclusion criteria
- History of cardiovascular, cerebrovascular, dermatological, and hematological diseases.
- History of pulmonary, hepatic, kidney, dermatologic and hematologic diseases.
- History of pregnancy, hypertension, diabetes mellitus, obesity, sleep apnea and neurological disorders.
- History of substance abuse.
- Participating in other drug or medical device studies.
- History of organ transplantation, including allogeneic stem cell and immune cell transplantation.
- Recent severe infection within 4 weeks.
- Received cancer treatment, including chemotherapy and radiotherapy, within 4 weeks.
- Underwent major surgery within 28 days.
Where it is running
1 location listed.
- Xuanwu Hospital, Capital Medical University - Beijing, Beijing Municipality, China